technetium has been researched along with Carcinoma, Pancreatic Ductal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bartholomeusz, D; Bezak, E; Hsieh, W; Hull, A; Li, Y; Pukala, TL; Staudacher, AH; Tieu, W | 1 |
Alencar, LMR; Bernardes, ES; Braga, TL; da Silva de Barros, AO; Dos Reis, SRR; Dos Santos, SN; Pinto, SR; Portilho, FL; Ricci-Junior, E; Santos-Oliveira, R | 1 |
2 other study(ies) available for technetium and Carcinoma, Pancreatic Ductal
Article | Year |
---|---|
Preliminary Development and Testing of C595 Radioimmunoconjugates for Targeting MUC1 Cancer Epitopes in Pancreatic Ductal Adenocarcinoma.
Topics: Antibodies, Monoclonal; Carcinoma, Pancreatic Ductal; Copper Radioisotopes; Epitopes; Gallium Radioisotopes; Humans; Immunoconjugates; Lutetium; Mucin-1; Pancreatic Neoplasms; Radioisotopes; Technetium | 2022 |
Octreotide Nanoparticles Showed Affinity for In Vivo MIA Paca-2 Inducted Pancreas Ductal Adenocarcinoma Mimicking Pancreatic Polypeptide-Secreting Tumor of the Distal Pancreas (PPoma).
Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Survival; Humans; Male; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Octreotide; Pancreas; Pancreatic Neoplasms; Pancreatic Polypeptide; Particle Size; Polyesters; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Somatostatin; Technetium; Tissue Distribution | 2019 |